Clinical Research Directory
Browse clinical research sites, groups, and studies.
Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and Outcome
Sponsor: Nantes University Hospital
Summary
Calciphylaxis, also called Calcific Uremic Arteriolopathy (CUA) is a lethal affection mostly affecting patient in end stage renal disease. The survival rate is described around 20 to 46% at one year. Clinical presentation is very painful skin lesions with ulceration mostly located on the trunk or thigh. Current knowledge about physiopathology, diagnostic practice and therapeutic is very limited. Actually there is no European study about calciphylaxis and risk factors, diagnostic practice and outcome factors.
Official title: Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and Outcome : a Multicentric, Retrospective Cohort
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
80
Start Date
2016-07-01
Completion Date
2016-10-31
Last Updated
2026-06-24
Healthy Volunteers
No
Conditions
Interventions
Calcific Uremic Arteriolopathy
Locations (1)
CHU de Nantes
Nantes, France